4
Changes in Ownership
Avalyn Pharma Inc. Filed Acc 0001193125-26-201863
10% owner acquired 1,275,486 shares (conversion)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Wellington Biomedical Innovation Master Investors (Cayman) II L.P. 10% owner | 2026-05-01 | Conversion | +1,275,486 | 1,275,486 | D | ||
| Derivatives | |||||||
| Wellington Biomedical Innovation Master Investors (Cayman) II L.P. 10% owner | 2026-05-01 | Conversion · Series C-1 Convertible Preferred Stock | −20,482,289 | 0 | D | ||
| Wellington Biomedical Innovation Master Investors (Cayman) II L.P. 10% owner | 2026-05-01 | Conversion · Series D Convertible Preferred Stock | −4,060,259 | 0 | D | ||
Loading xslF345X06/ownership.xml…